CoChat

DNase inhibits early biofilm formation in Pseudomonas aeruginosa- or Staphylococcus aureus-induced empyema models

Deng, Wusheng, Lei, Yanmei, Tang, Xiujia, Li, Dingbin, Liang, Jinhua, Luo, Jing, Liu, Liuyuan, Zhang, Wenshu, Ye, Liumei, Kong, Jinliang, Wang, Ke, Chen, Zhaoyan · 2022 · Frontiers in Cellular and Infection Microbiology
Cited by 50

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Anti-infection strategies against pleural empyema include the use of antibiotics and drainage treatments, but bacterial eradication rates remain low. A major challenge is the formation of biofilms in the pleural cavity. DNase has antibiofilm efficacy in vitro, and intrapleural therapy with DNase is recommended to treat pleural empyema, but the relevant mechanisms remain limited. Our aim was to investigate whether DNase I inhibit the early biofilm formation in Pseudomonas aeruginosa- or Staphylococcus aureus-induced empyema models. We used various assays, such as crystal violet staining, confocal laser scanning microscopy (CLSM) analysis, peptide nucleic acid-fluorescence in situ hybridization (PNA-FISH), and scanning electron microscopy (SEM) analysis. Our results suggested that DNase I significantly inhibited early biofilm formation in a dose-dependent manner, without affecting the growth of P. aeruginosa or S. aureus in vitro. CLSM analysis confirmed that DNase I decreased the biomass and thickness of both bacterial biofilms. The PNA-FISH and SEM analyses also revealed that DNase I inhibited early (24h) biofilm formation in two empyema models. Thus, the results indicated that DNase inhibited early (24h) biofilm formation in P. aeruginosa- or S. aureus-induced rabbit empyema models and showed its therapeutic potential against empyema biofilms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcimb.2022.917038

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 60

  1. Addala, 2021, Parapneumonic effusion and empyema, Clin. Chest Med., 42, 637, 10.1016/j.ccm.2021.08.001 · doi:10.1016/j.ccm.2021.08.001
  2. Alhede, 2020, The origin of extracellular DNA in bacterial biofilm infections in vivo, Pathog. Dis., 78, 10.1093/femspd/ftaa018 · DOI · Paper page
  3. Banu, 2017, Antivirulent properties of underexplored cinnamomum tamala essential oil and its synergistic effects with DNase against pseudomonas aeruginosa biofilms – an In vitro study, Front. Microbiol., 8, 10.3389/fmicb.2017.01144 · DOI
  4. Bedawi, 2021, Advances in pleural infection and malignancy, Eur. Respir. Rev., 30, 10.1183/16000617.0002-2020 · DOI
  5. Bedawi, 2019, Pleural infection: a closer look at the etiopathogenesis, microbiology and role of antibiotics, Expert Rev. Respir. Med., 13, 337, 10.1080/17476348.2019.1578212 · doi:10.1080/17476348.2019.1578212
  6. Buzzo, 2021, Z-form extracellular DNA is a structural component of the bacterial biofilm matrix, Cell, 184, 5740, 10.1016/j.cell.2021.10.010 · DOI · Paper page
  7. Chaddha, 2021, Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement, Lancet Respir. Med., 9, 1050, 10.1016/S2213-2600(20)30533-6 · DOI
  8. Chávez de Paz, 2008, Oral bacteria in biofilms exhibit slow reactivation from nutrient deprivation, Microbiol. (Reading England), 154, 1927, 10.1099/mic.0.2008/016576-0 · DOI · Paper page
  9. Chen, 2021, Identification of microbiome etiology associated with drug resistance in pleural empyema, Front. Cell Infect. Microbiol., 11, 10.3389/fcimb.2021.637018 · DOI
  10. Chen, 2016, Baicalein inhibits staphylococcus aureus biofilm formation and the quorum sensing system In vitro, PloS One, 11, 10.1371/journal.pone.0153468 · DOI · Paper page
  11. Coelho, 2021, Pyranoanthocyanins interfering with the quorum sensing of pseudomonas aeruginosa and staphylococcus aureus, Int. J. Mol. Sci., 22, 8559, 10.3390/ijms22168559 · DOI
  12. Davide, 2021, Extracellular DNA (eDNA). a major ubiquitous element of the bacterial biofilm architecture, Int. J. Mol. Sci., 22, 9100, 10.3390/ijms22169100 · DOI · Paper page
  13. Elsayed, 2018, Thoracoscopic management of early stages of empyema: is this the golden standard, J. Vis. Surg., 4, 114, 10.21037/jovs.2018.05.18 · doi:10.21037/jovs.2018.05.18
  14. Farisa Banu, 2017, Antivirulent properties of underexplored cinnamomum tamala essential oil and its synergistic effects with DNase against pseudomonas aeruginosa biofilms - an In vitro study, Front. Microbiol., 8, 10.3389/fmicb.2017.01144 · DOI
  15. Hartmann, 2021, Quantitative image analysis of microbial communities with BiofilmQ, Nat. Microbiol., 6, 151, 10.1038/s41564-020-00817-4 · DOI · Paper page
  16. Hassan, 2019, The microbiology of pleural infection in adults: a systematic review, Eur. Respir. J., 54, 1900542, 10.1183/13993003.00542-2019 · DOI
  17. Heydorn, 2000, Quantification of biofilm structures by the novel computer program COMSTAT, Microbiology-Sgm, 146, 2395, 10.1099/00221287-146-10-2395 · DOI · Paper page
  18. Idell, 2017, Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: The case for the fibrinolytic potential, Clin. Pulm Med., 24, 163, 10.1097/CPM.0000000000000216 · doi:10.1097/cpm.0000000000000216
  19. Jelle, 2022, The dynamic transcriptome during maturation of biofilms formed by methicillin-resistant staphylococcus aureus&13, Front. Microbiol., 13, 10.3389/fmicb.2022.882346 · DOI
  20. KaiLing, 2022, Anti-larval and anti-algal natural products from marine microorganisms as sources of anti-biofilm agents, Mar. Drugs, 20, 90, 10.3390/md20020090 · doi:10.3390/md20020090
  21. Karygianni, 2020, Combined DNase and proteinase treatment interferes with composition and structural integrity of multispecies oral biofilms, J. Clin. Med., 9, 983, 10.3390/jcm9040983 · DOI
  22. Karygianni, 2021, Single DNase or proteinase treatment induces change in composition and structural integrity of multispecies oral biofilms, Antibiotics (Basel), 10, 400, 10.3390/antibiotics10040400 · DOI
  23. Koo, 2017, Targeting microbial biofilms: current and prospective therapeutic strategies, Nat. Rev. Microbiol., 15, 740, 10.1038/nrmicro.2017.99 · DOI · Paper page
  24. Krychowiak, 2014, Combination of silver nanoparticles and drosera binata extract as a possible alternative for antibiotic treatment of burn wound infections caused by resistant staphylococcus aureus, PloS One, 9, 10.1371/journal.pone.0115727 · DOI
  25. Kumar, 2019, Antibiofilm potential of silver sulfadiazine-loaded nanoparticle formulations: A study on the effect of DNase-I on microbial biofilm and wound healing activity, Mol. pharmaceutics, 16, 3916, 10.1021/acs.molpharmaceut.9b00527 · DOI · Paper page
  26. Lacotte, 2022, Inhibition of In vitro clostridioides difficile biofilm formation by the probiotic yeast saccharomyces boulardii CNCM I-745 through modification of the extracellular matrix composition, Microorganisms, 10, 1082, 10.3390/microorganisms10061082 · DOI
  27. Lee, 2011, 3-indolylacetonitrile decreases escherichia coli O157:H7 biofilm formation and pseudomonas aeruginosa virulence, Environ. Microbiol., 13, 62, 10.1111/j.1462-2920.2010.02308.x · DOI · Paper page
  28. Lehtomaki, 2020, Pleural infection-an indicator of morbidity and increased burden on health care, Interact. Cardiovasc. Thorac. Surg., 31, 513, 10.1093/icvts/ivaa147 · DOI
  29. Lehtomaki, 2020, Trends in the incidence, etiology, treatment, and outcomes of pleural infections in adults over a decade in a Finnish university hospital, Scand. J. Surg., 109, 127, 10.1177/1457496919832146 · doi:10.1177/1457496919832146
  30. Liu, 2020, Encapsulated DNase improving the killing efficiency of antibiotics in staphylococcal biofilms, J. Mater Chem. B, 8, 4395, 10.1039/d0tb00441c · DOI
  31. Lukas, 2006, Analysis of a marine phototrophic biofilm by confocal laser scanning microscopy using the new image quantification software PHLIP, BMC Ecol., 6, 10.1186/1472-6785-6-1 · DOI · Paper page
  32. Luo, 2018, A sensitive thresholding method for confocal laser scanning microscope image stacks of microbial biofilms, Sci. Rep., 8, 13013, 10.1038/s41598-018-31012-5 · DOI
  33. Luo, 2016, Baicalein attenuates the quorum sensing-controlled virulence factors of pseudomonas aeruginosa and relieves the inflammatory response in p. aeruginosa-infected macrophages by downregulating the MAPK and NFkappaB signal-transduction pathways, Drug Des. Devel Ther., 10, 183, 10.2147/DDDT.S97221 · DOI
  34. Meraj, 2020, Anacardic acid encapsulated solid lipid nanoparticles for staphylococcus aureus biofilm therapy: chitosan and DNase coating improves antimicrobial activity, Drug deliv Trans. Res., 11, 305, 10.1007/s13346-020-00795-4 · DOI
  35. Mountcastle, 2021, Biofilm viability checker: An open-source tool for automated biofilm viability analysis from confocal microscopy images, NPJ Biofilms Microbiomes, 7, 44, 10.1038/s41522-021-00214-7 · DOI · Paper page
  36. Nourbakhsh, 2022, Bacterial biofilms and their resistance mechanisms: a brief look at treatment with natural agents, Folia Microbiol. (Praha), 67, 535, 10.1007/s12223-022-00955-8 · DOI
  37. Panlilio, 2021, The role of extracellular DNA in the formation, architecture, stability, and treatment of bacterial biofilms, Biotechnol. Bioeng, 118, 2129, 10.1002/bit.27760 · DOI · Paper page
  38. Pezzoni, 2020, Evaluation of viable cells in pseudomonas aeruginosa biofilmsby colony count and Live/Dead staining, Bio Protoc., 10, 10.21769/BioProtoc.3762 · DOI
  39. Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res., 29, 10.1093/nar/29.9.e45 · DOI · Paper page
  40. Rahman, 2011, Intrapleural use of tissue plasminogen activator and DNase in pleural infection, N Engl. J. Med., 365, 518, 10.1056/NEJMoa1012740 · DOI · Paper page
  41. Ramaraj, 2020, Combined effect of melittin and DNase on enterococcus faecalis biofilms and its susceptibility to sodium hypochlorite, Materials (Basel), 13, 3740, 10.3390/ma13173740 · DOI
  42. Rather, 2021, Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies, Braz. J. Microbiol., 52, 1701, 10.1007/s42770-021-00624-x · DOI · Paper page
  43. Rybtke, 2015, Pseudomonas aeruginosa biofilm infections: Community structure, antimicrobial tolerance and immune response, J. Mol. Biol., 427, 3628, 10.1016/j.jmb.2015.08.016 · DOI · Paper page
  44. Saharut, 2020, DNase-mediated eDNA removal enhances d-LL-31 activity against biofilms of bacteria isolated from chronic rhinosinusitis patients, Biofouling, 36, 1117, 10.1080/08927014.2020.1857741 · DOI
  45. Schlafer, 2018, Effect of DNase treatment on adhesion and early biofilm formation of enterococcus faecalis, Eur. Endod. J., 3, 82, 10.14744/eej.2018.55264 · DOI
  46. Shang, 2022, Clemastine inhibits the biofilm and hemolytic of staphylococcus aureus through the GdpP protein, Microbiol. Spectr., 10, e0054121, 10.1128/spectrum.00541-21 · DOI
  47. Sharma, 2019, Antibiotics versus biofilm: an emerging battleground in microbial communities, Antimicrobial Resist Infect Control, 8, 76, 10.1186/s13756-019-0533-3 · DOI · Paper page
  48. Sharma, 2018, Antibiofilm effect of DNase against single and mixed species biofilm, Foods, 7, 42, 10.3390/foods7030042 · DOI
  49. Sladjana, 2009, Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH), Microbiol. (Reading England), 155, 8), 10.1099/mic.0.028712-0 · DOI · Paper page
  50. Srikanth, 2021, Biosurfactant synergized with marine bacterial DNase disrupts polymicrobial biofilms, Folia Microbiol. (Praha), 66, 831, 10.1007/s12223-021-00876-y · DOI
  51. Sundaralingam, 2021, Management of pleural infection, Pulm Ther., 7, 59, 10.1007/s41030-020-00140-7 · doi:10.1007/s41030-020-00140-7
  52. Tetz, 2009, Effect of DNase and antibiotics on biofilm characteristics, Antimicrob. Agents Chemother., 53, 1204, 10.1128/AAC.00471-08 · DOI · Paper page
  53. Tsiry, 2015, The formation of biofilms by pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanisms, BioMed. Res. Int., 2015, 10.1155/2015/759348 · DOI · Paper page
  54. Wang, 2020, The characteristic of virulence, biofilm and antibiotic resistance of klebsiella pneumoniae, Int. J. Environ. Res. Public Health, 17, 6278, 10.3390/ijerph17176278 · DOI · Paper page
  55. Wei, 2019, Insulin treatment enhances pseudomonas aeruginosa biofilm formation by increasing intracellular cyclic di-GMP levels, leading to chronic wound infection and delayed wound healing, Am. J. Transl. Res., 11, 3261
  56. Xu, 2015, [Effect of DNase I on biofilm formation of staphylococcus aureus], Nan Fang Yi Ke Da Xue Xue Bao, 35, 1356
  57. Yin, 2022, Caffeic acid phenethyl ester (CAPE) inhibits cross-kingdom biofilm formation of streptococcus mutans and candida albicans, Microbiol. Spectrum, 10.1128/spectrum.01578-22 · DOI
  58. Yu, 2022, Andrographolide inhibits biofilm and virulence in listeria monocytogenes as a quorum-sensing inhibitor, Molecules, 27, 3234, 10.3390/molecules27103234 · doi:10.3390/molecules27103234
  59. Zhang, 2020, The effect of cyclic-di-GMP on biofilm formation by pseudomonas aeruginosa in a novel empyema model, Ann. Transl. Med., 8, 1146, 10.21037/atm-20-6022 · DOI
  60. Zhu, 2006, Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model, Chest, 129, 1577, 10.1378/chest.129.6.1577 · doi:10.1378/chest.129.6.1577

Cited by

See all 50

Metadata

Authors
Deng, W., Lei, Y., Tang, X., Li, D., Liang, J., Luo, J., Liu, L., Zhang, W., Ye, L., Kong, J., Wang, K., & Chen, Z.
Venue
Frontiers in Cellular and Infection Microbiology
Published
2022-10-12
Volume
12
ISSN
2235-2988
Cited by
50
References
3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.